Latest News & Features
Americas
AstraZeneca filed a patent infringement lawsuit against Mylan Pharmaceuticals and Kindeva Drug Delivery on Tuesday, claiming that their generic asthma Symbicort infringes a brand-new patent that was issued the same day. 28 April 2022
Americas
Akerman has hired Atlanta-based patent litigator Jeffrey Toney from McDermott Will & Emery. 28 April 2022
Big Pharma
US pharmaceutical and medical device industries have expressed concerns regarding the policies of several countries, according to the Office of the US Trade Representatives. 28 April 2022
Generics
BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder. 26 April 2022
Big Pharma
Senator Elizabeth Warren has urged the US Department of Health and Human Services to “break patent barriers” in order to foster competition to lower prescription drug prices. 26 April 2022
Generics
American health care company Aetna has convinced a California court to transfer its antitrust action claiming that Gilead and other drugmakers used pay-for-delay tactics to maintain high costs of HIV treatments. 25 April 2022
Americas
Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson subsidiary Janssen Pharmaceuticals. 21 April 2022
Big Pharma
Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal. 21 April 2022
article
Since the Nagoya Protocol was implemented in October 2014, lawyers, academics, and the life sciences industry broadly have been calling upon institutions such as the European Union for guidance on how to best abide by the new regulations. 21 April 2022
Big Pharma
In a victory for Novartis, the Delhi High Court in India has issued a permanent injunction against two India-based companies which had allegedly sought to make a generic version of the Hepatitis C treatment, Revolade. 19 April 2022